Celltium Corporation has been chosen to participate in the 'Market Expansion Type' of the 2022 Small and Medium Enterprise Technology Innovation Development Project, organized by the Ministry of SMEs and Startups. The company will receive research and development funding and will conduct research on discovering treatments for Charcot-Marie-Tooth disease using a high-throughput, large-scale drug screening platform.
Comments